Faes Farma Stock Forecast for 2023 - 2025 - 2030
Updated on 04/20/2024
Faes Farma Stock Forecast and Price Target
If the average price target of 3.65€ set by distinguished experts for Faes Farma over the past few weeks is reached this year, there would be a potential upside of approximately 14.42% from the last closing price in April, 2024. This potential increase is based on a high estimate of 4.33€ and a low estimate of 3.20€. If you're interested in FAE stock, it's important to compare it to other companies in the industry.
14.42% Upside
Faes Farma Fair Value Forecast for 2023 - 2025 - 2030
In the last four years, Faes Farma's Price has fallen from 3.75€ to 0.00€ – a 100.00% decrease. For the next year, analysts are expecting Fair Value to reach 4.19€ – an increase of 100.00%. Over the next eight years, experts predict that Fair Value will grow by 100.00%.
| Ticker | Name | Consensus | Stock Rating | Price | Buy/Sell | Price Target | Upside/Downside |
|---|---|---|---|---|---|---|---|
| ARGX Stock Forecast | argenx | Outperform |
4
|
337.30€ | Buy/Sell | 531.81€ | 30.15% |
| GMAB Stock Forecast | Genmab A/S | Outperform |
16
|
kr2.01k | Buy/Sell | kr2.71k | 27.87% |
| REC Stock Forecast | Recordati Industria Chimica e ... | Hold |
18
|
49.86€ | Buy/Sell | 48.61€ | 1.68% |
| ZEAL Stock Forecast | Zealand Pharma A/S | Outperform |
8
|
kr583.50 | Buy/Sell | kr357.00 | 39.67% |
| ORNBV Stock Forecast | Orion Oyj | Hold |
14
|
32.40€ | Buy/Sell | 42.52€ | 29.63% |
Faes Farma Revenue Forecast for 2023 - 2025 - 2030
In the last two years, Faes Farma's Revenue has grown by 12.21%, from 411.49€M to 461.72€M. For the next year, analysts are expecting Revenue to reach 479.00€M – an increase of 3.74%. Over the next seven years, experts predict that Revenue will grow by 7.13%.
| Ticker | Name | Consensus | Stock Rating | Price | Buy/Sell | Price Target | Upside/Downside |
|---|---|---|---|---|---|---|---|
| HIK Stock Forecast | Hikma Pharmaceuticals PLC | Outperform |
18
|
£17.99 | Buy/Sell | £28.11 | 64.42% |
| ALK B Stock Forecast | ALK-Abelló A/S | Outperform |
13
|
kr125.60 | Buy/Sell | kr109.25 | 5.89% |
| BHC Stock Forecast | Bausch Health Companies | Hold |
15
|
$8.69 | Buy/Sell | $9.50 | 15.07% |
.jpg)
Faes Farma Dividend per Share Forecast for 2023 - 2025 - 2030
Faes Farma's Dividend per Share has decreased In the last two years, from 0.20€ to 0.16€ – a 20.00% drop. In the following year, 4 experts forecast Faes Farma's Dividend per Share will decrease by 25.00%, to 0.12€. In 2030, professionals predict that Faes Farma's Dividend per Share will decrease by 18.37%, to 0.13€.
| Ticker | Name | Consensus | Stock Rating | Price | Buy/Sell | Price Target | Upside/Downside |
|---|---|---|---|---|---|---|---|
| MOR Stock Forecast | MorphoSys | Outperform |
6
|
67.70€ | Buy/Sell | 28.78€ | 0.44% |
| EVT Stock Forecast | Evotec | Outperform |
14
|
13.26€ | Buy/Sell | 37.33€ | 92.31% |
| INDV Stock Forecast | Indivior PLC | Buy |
14
|
£15.14 | Buy/Sell | £28.89 | 108.06% |
| Ticker | Name | Consensus | Stock Rating | Price | Buy/Sell | Price Target | Upside/Downside |
|---|---|---|---|---|---|---|---|
| ALM Stock Forecast | Almirall | Outperform |
16
|
8.24€ | Buy/Sell | 11.39€ | 39.56% |
| COPN Stock Forecast | Cosmo Pharmaceuticals N.V. | Buy |
12
|
CHF71.40 | Buy/Sell | CHF76.55 | 31.75% |
| PHM Stock Forecast | Pharma Mar | Outperform |
13
|
26.24€ | Buy/Sell | 50.20€ | 82.93% |
Faes Farma EBITDA Forecast for 2023 - 2025 - 2030
In the last two years, Faes Farma's EBITDA has grown by 13.24%, rising from 104.18€M to 117.97€M. For next year, analysts predict EBITDA of 126.98€M, which would mean an increase of 7.64%. Over the next eight years, experts predict that Faes Farma's EBITDA will grow at a rate of 6.44%.
| Ticker | Name | Consensus | Stock Rating | Price | Buy/Sell | Price Target | Upside/Downside |
|---|---|---|---|---|---|---|---|
| BSLN Stock Forecast | Basilea Pharmaceutica | Outperform |
6
|
CHF40.75 | Buy/Sell | CHF65.63 | 61.96% |
| DBV Stock Forecast | DBV Technologies | Outperform |
5
|
1.24€ | Buy/Sell | 4.07€ | 222.58% |
| MOLN Stock Forecast | Molecular Partners | Outperform |
4
|
CHF3.37 | Buy/Sell | CHF9.50 | 177.45% |
Faes Farma EBIT Forecast for 2023 - 2025 - 2030
In the last two years, Faes Farma's EBIT has grown, rising from 92.31€M to 101.92€M – a growth of 10.41%. In the next year, analysts believe that EBIT will reach 104.50€M – an increase of 2.53%. Professionals believe that By 2030, Faes Farma's EBIT will fall to 101.64€M – a 0.28% decrease from its current value.
Faes Farma EPS Price Prediction Forecast for 2023 - 2025 - 2030
In the last four years, Faes Farma's EPS has fallen from 0.25€ to 0.00€ – a 100.00% decrease. For the next year, analysts are expecting EPS to reach 0.28€ – an increase of 100.00%. Over the next eight years, experts predict that EPS will grow by 100.00%.
.jpg)